Pharmacist Moms Group

View More
Expert: Study Results Could Improve Glycemic Outcomes with Pharmacist Management of Insulin

Cole Daniels, PharmD, BCPS, discusses a quality improvement initiative for glycemic outcomes with pharmacist management of insulin.

Expert Discusses Pharmacists Role on Rural Access to Care, Aiding Health Equity

Tera Moore, PharmD, BCACP, discusses how the integration of pharmacists into team-based models could benefit patient access to care in rural populations.

Study Reinforces Safety of Taxane-Based Chemotherapies for Pregnant Patients With Breast Cancer

In an interview at the 2023 San Antonio Breast Cancer Symposium, Ana Ferrigno Guajardo, MD, discussed research into the safety and efficacy of taxane-based chemotherapy use in pregnant patients with breast cancer.

Final Data From NATALEE Trial Show Benefit of Ribociclib Across Subgroups

Gabriel N. Hortobagyi, MD, MACP, FASCO, a professor at the University of Texas MD Anderson Cancer Center, discussed the final data on invasive disease-free survival from the NATALEE trial of ribociclib in combination with a nonsteroid aromatase inhibitor (NSAI).

Expert: A Trauma-Informed Discussion for Pharmacist to Advance Health Equity

Tera Moore, PharmD, BCACP, discusses the principles of trauma-informed care, along with the physiologic response to trauma.

Expert: Pharmacists Play Key Role in Culturally Competent Care for Racially Diverse Patients

Mara Hofherr, PharmD, a clinical oncology pharmacist at Washington University, highlights key findings of the KEYNOTE-522 trial in comparison of outcomes between Black and White patients with triple-negative breast cancer.

Expert: Evolution of Management of Breast Cancer has "Undergone Profound Changes"

Gabriel Hortobagyi, MD, FACP, professor and chair emeritus of the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center discusses the changes in breast cancer management over the past decade.

Expert Discusses Engaging Federal and State Policymakers on Issues that Impact Health-System Pharmacy

Tom Kraus, JD discusses current federal regulatory and legislative issues that impact the practice of health-system pharmacy.

Expert: Oncology Teams Need Standardized Questionnaires to Discuss Social Determinants With Patients

Amelie G. Ramirez, DrPH, MPH, director of the Institute for Health Promotion Research at UT Health Science Center San Antonio, discussed the need for standardized questionnaires for clinicians to discuss social determinants of health with their oncology patients.

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy